相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。New prognostic scoring system for primary myelofibrosis based on a study of the International Working Group for Myelofibrosis Research and Treatment
Francisco Cervantes et al.
BLOOD (2009)
Nuclear translocation of urokinase-type plasminogen activator
Victoria Stepanova et al.
BLOOD (2008)
Pegylated interferon-alfa-2a induces complete hematologic and molecular responses with low toxicity in polycythemia vera
Jean-Jacques Kiladjian et al.
BLOOD (2008)
Symptomatische Milzbestrahlung bei fortgeschrittener Osteomyelosklerose*
J. Slanina et al.
DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT (2008)
A phase II study of 5-azacitidine for patients with primary and post-essential thrombocythemia/polycythemia vera myelofibrosis
A. Quintas-Cardama et al.
LEUKEMIA (2008)
JAK2 inhibitor therapy in myeloproliferative disorders: rationale, preclinical studies and ongoing clinical trials
A. Pardanani
LEUKEMIA (2008)
Proposals and rationale for revision of the World Health Organization diagnostic criteria for polycythemia vera, essential thrombocythemia, and primary myelotibrosis: recommendations from an ad hoc international expert panel
Ayalew Tefferi et al.
BLOOD (2007)
Lenalidomide therapy in del(5)(q31)-associated myelofibrosis:: cytogenetic and JAK2V617F molecular remissions
A. Tefferi et al.
LEUKEMIA (2007)
International Working Group (IWG) consensus criteria for treatment response in myelofibrosis with myeloid metaplasia, for the IWG for Myelofibrosis Research and Treatment (IWG-MRT)
Ayalew Tefferi et al.
BLOOD (2006)
Lenalidomide therapy in myelofibrosis with myeloid metaplasia
Ayalew Tefferi et al.
BLOOD (2006)
Allogeneic hematopoietic stern-cell transplantation with reduced-intensity conditioning in intermediate- or high-risk patients with myelofibrosis with myeloid metaplasia
D Rondelli et al.
BLOOD (2005)
Efficacy of lenalidomide in myelodysplastic syndromes
A List et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Long-term analysis of the palliative benefit of 2-chlorodeoxyadenosine for myelofibrosis with myeloid metaplasia
LN Faoro et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2005)
Allogeneic hematopoietic stem cell transplantation for myelofibrosis
HJ Deeg et al.
BLOOD (2003)
Nonhepatosplenic extramedullary hematopoiesis: Associated diseases, pathology, clinical course, and treatment
CA Koch et al.
MAYO CLINIC PROCEEDINGS (2003)
A phase 2 trial of combination low-dose thalidomide and prednisone for the treatment of myelofibrosis with myeloid metaplasia
RA Mesa et al.
BLOOD (2003)
Palliative irradiation of the spleen
JT McFarland et al.
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS (2003)
Low-dose, single-fraction, whole-lung radiotherapy for pulmonary hypertension associated with myelofibrosis with myeloid metaplasia
DP Steensma et al.
BRITISH JOURNAL OF HAEMATOLOGY (2002)
Melphalan treatment in patients with myelofibrosis with myeloid metaplasia
MC Petti et al.
BRITISH JOURNAL OF HAEMATOLOGY (2002)
Safety and efficacy of thalidomide in patients with myelofibrosis with myeloid metaplasia
G Barosi et al.
BRITISH JOURNAL OF HAEMATOLOGY (2001)
Splenectomy and hemopoietic stem cell transplantation for myelofibrosis
ZH Li et al.
BLOOD (2001)
Clinical and bone marrow effects of interferon alfa therapy in myelofibrosis with myeloid metaplasia
A Tefferi et al.
BLOOD (2001)
Safely and efficacy of splenic irradiation in the treatment of patients with idiopathic myelofibrosis: a report on 15 patients
R Bouabdallah et al.
LEUKEMIA RESEARCH (2000)
分享论文
